Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Samsung Bioepis Announces Positive Preliminary Phase 1 Data for SB27, Proposed Biosimilar to Keytruda (Pembrolizumab)

Summary by Hastings Tribune
INCHEON, Korea--(BUSINESS WIRE)--May 5, 2026-

4 Articles

Rutland HeraldRutland Herald
+3 Reposted by 3 other sources
Center

Samsung Bioepis Announces Positive Preliminary Phase 1 Data for SB27, Proposed Biosimilar to Keytruda (Pembrolizumab)

INCHEON, Korea--(BUSINESS WIRE)--May 5, 2026-

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Carroll County Mirror-Democrat broke the news in Mount Carroll, United States on Tuesday, May 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Samsung icon

Samsung

Incheon icon

Incheon

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal